Critical Illness Insurance Market By Application (Cancer, Heart Attack, Stroke, Others), By Premium Mode (Monthly, Quarterly, Half Yearly, Yearly), By End User (Individual, Businesses): Global Opportunity Analysis and Industry Forecast, 2021-2031

Critical Illness Insurance Market

Younger people are suffering from life-threatening diseases or critical ailments due to the sedentary lifestyle. According to insurance estimates, 40% of heart patients in India belong to the age group of 25-35 years. There is a rise in the cases of critical illnesses like cancer, lung diseases, and other chronic health ailments, which are not only costly to treat but also lead to a financial loss in case the breadwinner of a family is diagnosed with a problem. Unlike a regular individual health insurance policy that covers hospitalization expenses, a critical illness policy pays a fixed amount if the insured is diagnosed with any of the critical illness cover as mentioned in the policy document. Therefore, these are some of the major critical illness insurance market trends.

Furthermore, major players in the critical illness insurance market are undertaking various strategies to increase the competition and offer enhanced services to their customers. For instance, in January 2021, Breeze, an Omaha-based insurtech company, announced the launch of a critical care insurance product available to consumers on its digital platform. This strategic move expands the company's partnership with Assurity Life, which seeks to provide consumers with easier access to affordable insurance products in underserved markets. Launching an online critical illness insurance product expands Breeze's mission to protect Americans in their most financially vulnerable moments.

On the basis of end user, the individual segment is the highest growing segment. This is attributed to the fact that critical illness insurance for individuals can pay for costs not covered by traditional insurance. The money can also be used for nonmedical costs related to the illness, including transportation, child care, and others.

On the basis of region, North America attained the highest growth in 2021. This is attributed to the rise in the number of cases for patients suffering from life-threatening diseases such as kidney failure, cancer, heart attack, strokes, the modern lifestyle & the increasing prevalence of these diseases in the region. In addition, the critical illness plan supports coverage across specific life-threatening disorders, increasing the risk of falling prey to lifestyle diseases, augmenting the middle class, increasing life expectancy, and population growth is also propelling the market growth.

COVID-19 had a positive impact on the critical illness market since consumers were taking health insurance for covering the cost of hospitalization, they were also propelled to take critical illness insurance coverage as these critical diseases are increasing rapidly. Moreover, as people infected with the COVID-19 virus are more prone to critical illness such as heat diseases and others. Therefore, the demand for critical illness insurance increased during the pandemic which positively impacted the critical illness insurance market growth.

Key findings of the study

By application, the cancer segment led the critical illness insurance market in terms of revenue in 2021.

By premium mode, the monthly segment accounted for the highest critical illness insurance market share in 2021.

By region, North America generated the highest revenue for the critical illness insurance market size in 2021.

The key players profiled in the critical illness insurance market analysis are Aegon, AFLAC INCORPORATED, Allianz Care, American International Group, Inc., Aviva, AXA Hong Kong, Bajaj Allianz General Insurance Co. Ltd., Cigna, Future Generali India Insurance Company Ltd., Legal & General Group plc, Liberty Mutual Insurance, MetLife Services and Solutions, LLC., Royal London, Sun Life Assurance Company of Canada, United HealthCare Services, Inc., Modern Insurance Agency, Inc., and Plum Benefits Private Limited. These players have adopted various strategies to increase their market penetration and strengthen their position in the critical illness insurance industry.

Overview

The critical illness insurance cover provides the insured with financial security against various life-threatening health conditions such as kidney failures, cardiovascular diseases, and cancer. Critical illness insurance cover includes a lump sum payment in case the insured is diagnosed with a listed illness.

Rise in number of health issues due to unhealthy lifestyle of people causes serious illness such as kidney failures, heart attack, cancer and other such serious illness have increased the demand for critical illness insurance coverage among consumers. In addition, rise in awareness about the benefits of a critical illness insurance coverage among consumers is a major driving factor for the market. Moreover, the cost of treatment without having an insurance coverage may lead to huge medical bills for which customers opt for the critical illness insurance. These are some of the factors propelling the growth of the critical illness insurance market. However, high amount of premium for the critical illness insurance is a major factor limiting the growth of the market. On the contrary, smooth experience offered by the insurance coverage pertaining to reimbursement of medical bills and cashless treatments at best hospitals without the worry of high fees charged for operation and treatments is expected to provide lucrative growth opportunities in the coming years.

The critical illness insurance market is segmented on the basis of application, premium mode, end user, and region. By application, it is classified into cancer, heart attack, stroke, and others. By premium mode, it is categorized into monthly, quarterly, half yearly, and yearly. By application, it is bifurcated into individual, and businesses. The businesses segment is further sub segmented into group policies and individual policies. The group policies segment is further divided into simplified issue policies, and fully underwritten policies. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report analyzes the profiles of key players operating in the critical illness insurance market such as Aegon, AFLAC INCORPORATED, Allianz Care, American International Group, Inc., Aviva, AXA Hong Kong, Bajaj Allianz General Insurance Co. Ltd., Cigna, Future Generali India Insurance Company Ltd., Legal & General Group plc, Liberty Mutual Insurance, MetLife Services and Solutions, LLC., Royal London, Sun Life Assurance Company of Canada, United HealthCare Services, Inc., Modern Insurance Agency, Inc., and Plum Benefits Private Limited. These players have adopted various strategies to increase their market penetration and strengthen their position in the critical illness insurance industry.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the critical illness insurance market analysis from 2021 to 2031 to identify the prevailing critical illness insurance market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the critical illness insurance market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global critical illness insurance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Plum Benefits Private Limite

Scope of Critical Illness Insurance Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Cancer

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Heart Attack

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Stroke

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Others

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Monthly

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Quarterly

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Half Yearly

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Yearly

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Individual

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Businesses

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Application

7.2.3 North America Market size and forecast, by Premium Mode

7.2.4 North America Market size and forecast, by End User

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Application

7.2.5.1.2 Market size and forecast, by Premium Mode

7.2.5.1.3 Market size and forecast, by End User

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Application

7.2.5.2.2 Market size and forecast, by Premium Mode

7.2.5.2.3 Market size and forecast, by End User

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Application

7.3.3 Europe Market size and forecast, by Premium Mode

7.3.4 Europe Market size and forecast, by End User

7.3.5 Europe Market size and forecast, by country

7.3.5.1 UK

7.3.5.1.1 Market size and forecast, by Application

7.3.5.1.2 Market size and forecast, by Premium Mode

7.3.5.1.3 Market size and forecast, by End User

7.3.5.2 Germany

7.3.5.2.1 Market size and forecast, by Application

7.3.5.2.2 Market size and forecast, by Premium Mode

7.3.5.2.3 Market size and forecast, by End User

7.3.5.3 France

7.3.5.3.1 Market size and forecast, by Application

7.3.5.3.2 Market size and forecast, by Premium Mode

7.3.5.3.3 Market size and forecast, by End User

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Application

7.3.5.4.2 Market size and forecast, by Premium Mode

7.3.5.4.3 Market size and forecast, by End User

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Application

7.3.5.5.2 Market size and forecast, by Premium Mode

7.3.5.5.3 Market size and forecast, by End User

7.3.5.6 Netherlands

7.3.5.6.1 Market size and forecast, by Application

7.3.5.6.2 Market size and forecast, by Premium Mode

7.3.5.6.3 Market size and forecast, by End User

7.3.5.7 Rest of Europe

7.3.5.7.1 Market size and forecast, by Application

7.3.5.7.2 Market size and forecast, by Premium Mode

7.3.5.7.3 Market size and forecast, by End User

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Application

7.4.3 Asia-Pacific Market size and forecast, by Premium Mode

7.4.4 Asia-Pacific Market size and forecast, by End User

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 China

7.4.5.1.1 Market size and forecast, by Application

7.4.5.1.2 Market size and forecast, by Premium Mode

7.4.5.1.3 Market size and forecast, by End User

7.4.5.2 India

7.4.5.2.1 Market size and forecast, by Application

7.4.5.2.2 Market size and forecast, by Premium Mode

7.4.5.2.3 Market size and forecast, by End User

7.4.5.3 Japan

7.4.5.3.1 Market size and forecast, by Application

7.4.5.3.2 Market size and forecast, by Premium Mode

7.4.5.3.3 Market size and forecast, by End User

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by Application

7.4.5.4.2 Market size and forecast, by Premium Mode

7.4.5.4.3 Market size and forecast, by End User

7.4.5.5 Singapore

7.4.5.5.1 Market size and forecast, by Application

7.4.5.5.2 Market size and forecast, by Premium Mode

7.4.5.5.3 Market size and forecast, by End User

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Market size and forecast, by Application

7.4.5.6.2 Market size and forecast, by Premium Mode

7.4.5.6.3 Market size and forecast, by End User

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Application

7.5.3 LAMEA Market size and forecast, by Premium Mode

7.5.4 LAMEA Market size and forecast, by End User

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Latin America

7.5.5.1.1 Market size and forecast, by Application

7.5.5.1.2 Market size and forecast, by Premium Mode

7.5.5.1.3 Market size and forecast, by End User

7.5.5.2 Middle East

7.5.5.2.1 Market size and forecast, by Application

7.5.5.2.2 Market size and forecast, by Premium Mode

7.5.5.2.3 Market size and forecast, by End User

7.5.5.3 Africa

7.5.5.3.1 Market size and forecast, by Application

7.5.5.3.2 Market size and forecast, by Premium Mode

7.5.5.3.3 Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Aegon

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 AFLAC INCORPORATED

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Allianz Care

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 American International Group, Inc.

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Aviva

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 AXA

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Bajaj Allianz General Insurance Co. Ltd.

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Cigna

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Future Generali India Insurance Company Ltd.

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Legal & General Group plc

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and developments

9.11 Liberty Mutual Insurance

9.11.1 Company overview

9.11.2 Company snapshot

9.11.3 Operating business segments

9.11.4 Product portfolio

9.11.5 Business performance

9.11.6 Key strategic moves and developments

9.12 MetLife Services and Solutions, LLC.

9.12.1 Company overview

9.12.2 Company snapshot

9.12.3 Operating business segments

9.12.4 Product portfolio

9.12.5 Business performance

9.12.6 Key strategic moves and developments

9.13 Royal London

9.13.1 Company overview

9.13.2 Company snapshot

9.13.3 Operating business segments

9.13.4 Product portfolio

9.13.5 Business performance

9.13.6 Key strategic moves and developments

9.14 Sun Life Assurance Company of Canada

9.14.1 Company overview

9.14.2 Company snapshot

9.14.3 Operating business segments

9.14.4 Product portfolio

9.14.5 Business performance

9.14.6 Key strategic moves and developments

9.15 United HealthCare Services, Inc.

9.15.1 Company overview

9.15.2 Company snapshot

9.15.3 Operating business segments

9.15.4 Product portfolio

9.15.5 Business performance

9.15.6 Key strategic moves and developments

9.16 Modern Insurance Agency, Inc.

9.16.1 Company overview

9.16.2 Company snapshot

9.16.3 Operating business segments

9.16.4 Product portfolio

9.16.5 Business performance

9.16.6 Key strategic moves and developments

9.17 Plum Benefits Private Limited

9.17.1 Company overview

9.17.2 Company snapshot

9.17.3 Operating business segments

9.17.4 Product portfolio

9.17.5 Business performance

9.17.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 2. CRITICAL ILLNESS INSURANCE MARKET, FOR CANCER, BY REGION, 2021-2031 ($BILLION)

TABLE 3. CRITICAL ILLNESS INSURANCE MARKET FOR CANCER, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 4. CRITICAL ILLNESS INSURANCE MARKET, FOR HEART ATTACK, BY REGION, 2021-2031 ($BILLION)

TABLE 5. CRITICAL ILLNESS INSURANCE MARKET FOR HEART ATTACK, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 6. CRITICAL ILLNESS INSURANCE MARKET, FOR STROKE, BY REGION, 2021-2031 ($BILLION)

TABLE 7. CRITICAL ILLNESS INSURANCE MARKET FOR STROKE, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 8. CRITICAL ILLNESS INSURANCE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($BILLION)

TABLE 9. CRITICAL ILLNESS INSURANCE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 10. GLOBAL CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 11. CRITICAL ILLNESS INSURANCE MARKET, FOR MONTHLY, BY REGION, 2021-2031 ($BILLION)

TABLE 12. CRITICAL ILLNESS INSURANCE MARKET FOR MONTHLY, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 13. CRITICAL ILLNESS INSURANCE MARKET, FOR QUARTERLY, BY REGION, 2021-2031 ($BILLION)

TABLE 14. CRITICAL ILLNESS INSURANCE MARKET FOR QUARTERLY, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 15. CRITICAL ILLNESS INSURANCE MARKET, FOR HALF YEARLY, BY REGION, 2021-2031 ($BILLION)

TABLE 16. CRITICAL ILLNESS INSURANCE MARKET FOR HALF YEARLY, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 17. CRITICAL ILLNESS INSURANCE MARKET, FOR YEARLY, BY REGION, 2021-2031 ($BILLION)

TABLE 18. CRITICAL ILLNESS INSURANCE MARKET FOR YEARLY, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 19. GLOBAL CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 20. CRITICAL ILLNESS INSURANCE MARKET, FOR INDIVIDUAL, BY REGION, 2021-2031 ($BILLION)

TABLE 21. CRITICAL ILLNESS INSURANCE MARKET FOR INDIVIDUAL, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 22. CRITICAL ILLNESS INSURANCE MARKET, FOR BUSINESSES, BY REGION, 2021-2031 ($BILLION)

TABLE 23. CRITICAL ILLNESS INSURANCE MARKET FOR BUSINESSES, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 24. CRITICAL ILLNESS INSURANCE MARKET, BY REGION, 2021-2031 ($BILLION)

TABLE 25. NORTH AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 26. NORTH AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 27. NORTH AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 28. NORTH AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 29. U.S. CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 30. U.S. CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 31. U.S. CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 32. CANADA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 33. CANADA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 34. CANADA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 35. EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 36. EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 37. EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 38. EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 39. UK CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 40. UK CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 41. UK CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 42. GERMANY CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 43. GERMANY CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 44. GERMANY CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 45. FRANCE CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 46. FRANCE CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 47. FRANCE CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 48. ITALY CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 49. ITALY CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 50. ITALY CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 51. SPAIN CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 52. SPAIN CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 53. SPAIN CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 54. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 55. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 56. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 57. REST OF EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 58. REST OF EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 59. REST OF EUROPE CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 60. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 61. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 62. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 63. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 64. CHINA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 65. CHINA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 66. CHINA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 67. INDIA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 68. INDIA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 69. INDIA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 70. JAPAN CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 71. JAPAN CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 72. JAPAN CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 73. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 74. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 75. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 76. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 77. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 78. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 79. REST OF ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 80. REST OF ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 81. REST OF ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 82. LAMEA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 83. LAMEA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 84. LAMEA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 85. LAMEA CRITICAL ILLNESS INSURANCE MARKET, BY COUNTRY, 2021-2031 ($BILLION)

TABLE 86. LATIN AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 87. LATIN AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 88. LATIN AMERICA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 89. MIDDLE EAST CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 90. MIDDLE EAST CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 91. MIDDLE EAST CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 92. AFRICA CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION, 2021-2031 ($BILLION)

TABLE 93. AFRICA CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE, 2021-2031 ($BILLION)

TABLE 94. AFRICA CRITICAL ILLNESS INSURANCE MARKET, BY END USER, 2021-2031 ($BILLION)

TABLE 95.AEGON: COMPANY SNAPSHOT

TABLE 96.AEGON: OPERATING SEGMENTS

TABLE 97.AEGON: PRODUCT PORTFOLIO

TABLE 98.AEGON: NET SALES,

TABLE 99.AEGON: KEY STRATERGIES

TABLE 100.AFLAC INCORPORATED: COMPANY SNAPSHOT

TABLE 101.AFLAC INCORPORATED: OPERATING SEGMENTS

TABLE 102.AFLAC INCORPORATED: PRODUCT PORTFOLIO

TABLE 103.AFLAC INCORPORATED: NET SALES,

TABLE 104.AFLAC INCORPORATED: KEY STRATERGIES

TABLE 105.ALLIANZ CARE: COMPANY SNAPSHOT

TABLE 106.ALLIANZ CARE: OPERATING SEGMENTS

TABLE 107.ALLIANZ CARE: PRODUCT PORTFOLIO

TABLE 108.ALLIANZ CARE: NET SALES,

TABLE 109.ALLIANZ CARE: KEY STRATERGIES

TABLE 110.AMERICAN INTERNATIONAL GROUP, INC.: COMPANY SNAPSHOT

TABLE 111.AMERICAN INTERNATIONAL GROUP, INC.: OPERATING SEGMENTS

TABLE 112.AMERICAN INTERNATIONAL GROUP, INC.: PRODUCT PORTFOLIO

TABLE 113.AMERICAN INTERNATIONAL GROUP, INC.: NET SALES,

TABLE 114.AMERICAN INTERNATIONAL GROUP, INC.: KEY STRATERGIES

TABLE 115.AVIVA: COMPANY SNAPSHOT

TABLE 116.AVIVA: OPERATING SEGMENTS

TABLE 117.AVIVA: PRODUCT PORTFOLIO

TABLE 118.AVIVA: NET SALES,

TABLE 119.AVIVA: KEY STRATERGIES

TABLE 120.AXA: COMPANY SNAPSHOT

TABLE 121.AXA: OPERATING SEGMENTS

TABLE 122.AXA: PRODUCT PORTFOLIO

TABLE 123.AXA: NET SALES,

TABLE 124.AXA: KEY STRATERGIES

TABLE 125.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD.: COMPANY SNAPSHOT

TABLE 126.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD.: OPERATING SEGMENTS

TABLE 127.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD.: PRODUCT PORTFOLIO

TABLE 128.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD.: NET SALES,

TABLE 129.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD.: KEY STRATERGIES

TABLE 130.CIGNA: COMPANY SNAPSHOT

TABLE 131.CIGNA: OPERATING SEGMENTS

TABLE 132.CIGNA: PRODUCT PORTFOLIO

TABLE 133.CIGNA: NET SALES,

TABLE 134.CIGNA: KEY STRATERGIES

TABLE 135.FUTURE GENERALI INDIA INSURANCE COMPANY LTD.: COMPANY SNAPSHOT

TABLE 136.FUTURE GENERALI INDIA INSURANCE COMPANY LTD.: OPERATING SEGMENTS

TABLE 137.FUTURE GENERALI INDIA INSURANCE COMPANY LTD.: PRODUCT PORTFOLIO

TABLE 138.FUTURE GENERALI INDIA INSURANCE COMPANY LTD.: NET SALES,

TABLE 139.FUTURE GENERALI INDIA INSURANCE COMPANY LTD.: KEY STRATERGIES

TABLE 140.LEGAL & GENERAL GROUP PLC: COMPANY SNAPSHOT

TABLE 141.LEGAL & GENERAL GROUP PLC: OPERATING SEGMENTS

TABLE 142.LEGAL & GENERAL GROUP PLC: PRODUCT PORTFOLIO

TABLE 143.LEGAL & GENERAL GROUP PLC: NET SALES,

TABLE 144.LEGAL & GENERAL GROUP PLC: KEY STRATERGIES

TABLE 145.LIBERTY MUTUAL INSURANCE: COMPANY SNAPSHOT

TABLE 146.LIBERTY MUTUAL INSURANCE: OPERATING SEGMENTS

TABLE 147.LIBERTY MUTUAL INSURANCE: PRODUCT PORTFOLIO

TABLE 148.LIBERTY MUTUAL INSURANCE: NET SALES,

TABLE 149.LIBERTY MUTUAL INSURANCE: KEY STRATERGIES

TABLE 150.METLIFE SERVICES AND SOLUTIONS, LLC.: COMPANY SNAPSHOT

TABLE 151.METLIFE SERVICES AND SOLUTIONS, LLC.: OPERATING SEGMENTS

TABLE 152.METLIFE SERVICES AND SOLUTIONS, LLC.: PRODUCT PORTFOLIO

TABLE 153.METLIFE SERVICES AND SOLUTIONS, LLC.: NET SALES,

TABLE 154.METLIFE SERVICES AND SOLUTIONS, LLC.: KEY STRATERGIES

TABLE 155.ROYAL LONDON: COMPANY SNAPSHOT

TABLE 156.ROYAL LONDON: OPERATING SEGMENTS

TABLE 157.ROYAL LONDON: PRODUCT PORTFOLIO

TABLE 158.ROYAL LONDON: NET SALES,

TABLE 159.ROYAL LONDON: KEY STRATERGIES

TABLE 160.SUN LIFE ASSURANCE COMPANY OF CANADA: COMPANY SNAPSHOT

TABLE 161.SUN LIFE ASSURANCE COMPANY OF CANADA: OPERATING SEGMENTS

TABLE 162.SUN LIFE ASSURANCE COMPANY OF CANADA: PRODUCT PORTFOLIO

TABLE 163.SUN LIFE ASSURANCE COMPANY OF CANADA: NET SALES,

TABLE 164.SUN LIFE ASSURANCE COMPANY OF CANADA: KEY STRATERGIES

TABLE 165.UNITED HEALTHCARE SERVICES, INC.: COMPANY SNAPSHOT

TABLE 166.UNITED HEALTHCARE SERVICES, INC.: OPERATING SEGMENTS

TABLE 167.UNITED HEALTHCARE SERVICES, INC.: PRODUCT PORTFOLIO

TABLE 168.UNITED HEALTHCARE SERVICES, INC.: NET SALES,

TABLE 169.UNITED HEALTHCARE SERVICES, INC.: KEY STRATERGIES

TABLE 170.MODERN INSURANCE AGENCY, INC.: COMPANY SNAPSHOT

TABLE 171.MODERN INSURANCE AGENCY, INC.: OPERATING SEGMENTS

TABLE 172.MODERN INSURANCE AGENCY, INC.: PRODUCT PORTFOLIO

TABLE 173.MODERN INSURANCE AGENCY, INC.: NET SALES,

TABLE 174.MODERN INSURANCE AGENCY, INC.: KEY STRATERGIES

TABLE 175.PLUM BENEFITS PRIVATE LIMITED: COMPANY SNAPSHOT

TABLE 176.PLUM BENEFITS PRIVATE LIMITED: OPERATING SEGMENTS

TABLE 177.PLUM BENEFITS PRIVATE LIMITED: PRODUCT PORTFOLIO

TABLE 178.PLUM BENEFITS PRIVATE LIMITED: NET SALES,

TABLE 179.PLUM BENEFITS PRIVATE LIMITED: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.CRITICAL ILLNESS INSURANCE MARKET SEGMENTATION

FIGURE 2.CRITICAL ILLNESS INSURANCE MARKET,2021-2031

FIGURE 3.CRITICAL ILLNESS INSURANCE MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.CRITICAL ILLNESS INSURANCE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.CRITICAL ILLNESS INSURANCE MARKET,BY APPLICATION,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CANCER CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HEART ATTACK CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF STROKE CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 17.CRITICAL ILLNESS INSURANCE MARKET,BY PREMIUM MODE,2021(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MONTHLY CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF QUARTERLY CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HALF YEARLY CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF YEARLY CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 22.CRITICAL ILLNESS INSURANCE MARKET,BY END USER,2021(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF INDIVIDUAL CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF BUSINESSES CRITICAL ILLNESS INSURANCE MARKET,2021-2031(%)

FIGURE 25.CRITICAL ILLNESS INSURANCE MARKET BY REGION,2021

FIGURE 26.U.S. CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 27.CANADA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 28.UK CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 29.GERMANY CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 30.FRANCE CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 31.ITALY CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 32.SPAIN CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 33.NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 34.REST OF EUROPE CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 35.CHINA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 36.INDIA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 37.JAPAN CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 38.AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 39.SINGAPORE CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 40.REST OF ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 41.LATIN AMERICA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 42.MIDDLE EAST CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 43.AFRICA CRITICAL ILLNESS INSURANCE MARKET,2021-2031($BILLION)

FIGURE 44. TOP WINNING STRATEGIES, BY YEAR

FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 48.COMPETITIVE DASHBOARD

FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 50.AEGON.: NET SALES ,($BILLION)

FIGURE 51.AFLAC INCORPORATED.: NET SALES ,($BILLION)

FIGURE 52.ALLIANZ CARE.: NET SALES ,($BILLION)

FIGURE 53.AMERICAN INTERNATIONAL GROUP, INC..: NET SALES ,($BILLION)

FIGURE 54.AVIVA.: NET SALES ,($BILLION)

FIGURE 55.AXA.: NET SALES ,($BILLION)

FIGURE 56.BAJAJ ALLIANZ GENERAL INSURANCE CO. LTD..: NET SALES ,($BILLION)

FIGURE 57.CIGNA.: NET SALES ,($BILLION)

FIGURE 58.FUTURE GENERALI INDIA INSURANCE COMPANY LTD..: NET SALES ,($BILLION)

FIGURE 59.LEGAL & GENERAL GROUP PLC.: NET SALES ,($BILLION)

FIGURE 60.LIBERTY MUTUAL INSURANCE.: NET SALES ,($BILLION)

FIGURE 61.METLIFE SERVICES AND SOLUTIONS, LLC..: NET SALES ,($BILLION)

FIGURE 62.ROYAL LONDON.: NET SALES ,($BILLION)

FIGURE 63.SUN LIFE ASSURANCE COMPANY OF CANADA.: NET SALES ,($BILLION)

FIGURE 64.UNITED HEALTHCARE SERVICES, INC..: NET SALES ,($BILLION)

FIGURE 65.MODERN INSURANCE AGENCY, INC..: NET SALES ,($BILLION)

FIGURE 66.PLUM BENEFITS PRIVATE LIMITED.: NET SALES ,($BILLION